Overview
ASTH market data
Price History
ASTH price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ASTH. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
TD Cowen Maintains Buy on Astrana Health, Raises Price Target to $50Benzinga · Jul 14, 2026, 3:21 PM
BTIG Maintains Buy on Astrana Health, Raises Price Target to $65Benzinga · Jul 14, 2026, 9:49 AM
8-K filing — Astrana Health, Inc. (ASTH)SEC EDGAR · Jul 13, 2026, 12:05 PM
BTIG Reiterates Buy on Astrana Health, Maintains $50 Price TargetBenzinga · Jun 2, 2026, 10:12 AM
Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50Benzinga · May 26, 2026, 6:55 PM
Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $47Benzinga · May 14, 2026, 2:38 PM
Barclays Maintains Equal-Weight on Astrana Health, Raises Price Target to $37Benzinga · May 11, 2026, 1:16 PM